Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2001;21:1366-1372
doi: 10.1161/hq0801.093864
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mensenkamp, A. R.
Right arrow Articles by Kuipers, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mensenkamp, A. R.
Right arrow Articles by Kuipers, F.
Related Collections
Right arrow Animal models of human disease
Right arrow Other arteriosclerosis
Right arrow Genetically altered mice
Right arrow Lipid and lipoprotein metabolism
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2001;21:1366.)
© 2001 American Heart Association, Inc.


Atherosclerosis and Lipoproteins

Mice Expressing Only the Mutant APOE3Leiden Gene Show Impaired VLDL Secretion

Arjen R. Mensenkamp; Bas Teusink; Julius F.W. Baller; Henk Wolters; Rick Havinga; Ko Willems van Dijk; Louis M. Havekes; Folkert Kuipers

From the Groningen University Institute for Drug Exploration (A.R.M., J.F.W.B., H.W., R.H., F.K.), Center for Liver, Digestive, and Metabolic Diseases, Faculty of Medical Sciences and University Hospital Groningen, Groningen, the Netherlands; the Gaubius Laboratory TNO-PG (B.T., L.M.H.), Leiden, the Netherlands; and the Departments of Human Genetics (K.W.v.D.) and General Internal Medicine and Cardiology (L.M.H.), Leiden University, Leiden, the Netherlands.

Correspondence to Folkert Kuipers, PhD, Groningen University Institute for Drug Exploration, Center for Liver, Digestive, and Metabolic Diseases, University Hospital Groningen, CMC IV, Room Y2115, Hanzeplein 1, 9713 GZ Groningen, Netherlands. E-mail f.kuipers{at}med.rug.nl

Abstract— Apolipoprotein E (apoE)-deficient mice develop hepatic steatosis and show impaired very low density lipoprotein (VLDL)-triglyceride (TG) secretion. These effects are normalized on the introduction of the human APOE3 gene. To assess whether this apoE effect is isoform specific, we studied hepatic lipid metabolism in mice expressing either APOE3 or the mutant APOE3Leiden on apoe-/- or apoe+/- backgrounds. The transgenes were expressed mainly in periportal hepatocytes, as revealed by in situ hybridization. Mice expressing APOE3Leiden, on the apoe-/- and apoe+/- backgrounds, had fatty livers, which were absent in APOE3/apoe-/- mice. APOE3Leiden/apoe-/- mice showed a strongly reduced VLDL-TG secretion compared with APOE3/apoe-/- mice (48±14 versus 82±10 µmol/kg per hour, respectively). The presence of a single mouse apoe allele increased VLDL-TG secretion in APOE3Leiden/apoe+/- mice (121±43 µ mol/kg per hour) compared with APOE3Leiden/apoe-/- mice. These results show that APOE3Leiden does not prevent development of a fatty liver and does not normalize VLDL-TG secretion in mice with an apoE-deficient background. The presence of a single mouse apoe allele is sufficient to normalize the APOE3Leiden-associated reduction of VLDL-TG secretion but does not prevent steatosis. We conclude that apoE-mediated stimulation of VLDL secretion is isoform specific.


Key Words: very low density lipoproteins • apolipoprotein E • lipoprotein assembly • lipoprotein secretion • steatosis




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
D. A. Blasiole, A. T. Oler, and A. D. Attie
Regulation of ApoB Secretion by the Low Density Lipoprotein Receptor Requires Exit from the Endoplasmic Reticulum and Interaction with ApoE or ApoB
J. Biol. Chem., April 25, 2008; 283(17): 11374 - 11381.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
I. Duivenvoorden, B. Teusink, P. C. N. Rensen, F. Kuipers, J. A. Romijn, L. M. Havekes, and P. J. Voshol
Acute inhibition of hepatic {beta}-oxidation in APOE*3Leiden mice does not affect hepatic VLDL secretion or insulin sensitivity
J. Lipid Res., May 1, 2005; 46(5): 988 - 993.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
C. H. Wiegman, R. H.J. Bandsma, M. Ouwens, F. H. van der Sluijs, R. Havinga, T. Boer, D.-J. Reijngoud, J. A. Romijn, and F. Kuipers
Hepatic VLDL Production in ob/ob Mice Is Not Stimulated by Massive De Novo Lipogenesis but Is Less Sensitive to the Suppressive Effects of Insulin
Diabetes, May 1, 2003; 52(5): 1081 - 1089.
[Abstract] [Full Text] [PDF]